Viewing nowCombinationEmpaangduo Extended-Release Tablet 5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202500684 · Approved 2025.03.25 · Insurance code 657309210
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is particularly effective for patients whose blood sugar levels are not adequately controlled and should be used with caution in cases of cardiovascular disease. This helps with blood sugar management and reduces the risk of complications associated with diabetes.
For antidiabetic therapy, the dose of this medicine should be determined by considering each patient's current treatment, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin hydrochloride extended-release 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily in the evening with a meal. To reduce gastrointestinal adverse reactions associated with metformin use, the metformin hydrochloride dose should be increased gradually. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. Take one 25/1000 mg or 10/1000 mg extended-release tablet once daily. Patients taking the 12.5/1000 mg or 5/1000 mg extended-release tablet should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended initial daily dose when taking this medicine is empagliflozin 10 mg plus the patient's current metformin dose. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg. Patients switching from concomitant empagliflozin and metformin therapy to this medicine should receive their previous doses of empagliflozin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When this medicine is coadministered with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. Because dose adjustment based on renal function is required, renal function should be assessed before treatment with this medicine and periodically thereafter. No dose adjustment of this medicine is required in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], if well tolerated and not accompanied by other conditions that may increase the risk of lactic acidosis, this medicine may be used by adjusting the metformin hydrochloride dose as follows. - Since the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If creatinine clearance (CrCl) decreases to below 45 mL/min or estimated glomerular filtration rate (eGFR) decreases to below 45 mL/min/1.73m2, discontinue this medicine immediately. In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication helps to control blood sugar levels. However, there are several precautions to consider while taking this medication. First, it can rarely cause a serious condition known as lactic acidosis. Lactic acidosis can lead to a dangerous accumulation of lactic acid in the body, so if symptoms such as sudden muscle pain, shortness of breath, weakness, or abdominal pain occur, consult a doctor immediately. Second, when taking this medication with insulin or other diabetes medications, caution is required as it may cause hypoglycemia, meaning blood sugar levels drop too low. Symptoms of hypoglycemia include dizziness, headache, cold sweats, and severe fatigue, and immediate action should be taken if these symptoms occur. Third, patients with poor kidney function should not take this medication. Decreased kidney function may cause the drug to accumulate in the body and worsen side effects. Regular kidney function tests should be performed before and during treatment. Fourth, during times of dehydration, severe infection, acute heart issues, or before and after surgery when the body's condition deteriorates rapidly, the use of this medication should be temporarily halted and resumed only after recovery. Fifth, this medication must be discontinued before and after imaging tests using iodinated contrast agents, and resuming should occur only after confirming normal kidney function after the test. Sixth, this medication may increase the risk of genital infections and urinary tract infections; therefore, prompt treatment is necessary if infection symptoms appear. Seventh, this medication can decrease vitamin B12 levels, so patients taking it for a long time should periodically check their vitamin B12 levels. Eighth, it is safest for women who are pregnant or may become pregnant to avoid taking this medication, and it is also recommended to avoid use while breastfeeding. Ninth, elderly or frail patients should take caution as the risk of side effects such as dehydration or hypotension is higher when taking this medication. Finally, this medication should be swallowed whole and not crushed or chewed. It is normal for the outer coating of the tablet to appear in the stool. During the treatment with this medication, it is important to adhere to the above precautions and consult medical personnel immediately if any abnormal symptoms arise.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the medication.
Dark yellowish-green oval extended-release film-coated tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.